These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37263346)

  • 1. Transcription Factor Forkhead Box O1 Mediates Transforming Growth Factor-β1-Induced Apoptosis in Hepatocytes.
    Chen Y; Pan Q; Liao W; Ai W; Yang S; Guo S
    Am J Pathol; 2023 Sep; 193(9):1143-1155. PubMed ID: 37263346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte FoxO1 Deficiency Protects From Liver Fibrosis via Reducing Inflammation and TGF-β1-mediated HSC Activation.
    Pan Q; Gao M; Kim D; Ai W; Yang W; Jiang W; Brashear W; Dai Y; Li S; Sun Y; Qi Y; Guo S
    Cell Mol Gastroenterol Hepatol; 2024; 17(1):41-58. PubMed ID: 37678798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reciprocal Regulation of Hepatic TGF-β1 and Foxo1 Controls Gluconeogenesis and Energy Expenditure.
    Pan Q; Ai W; Chen Y; Kim DM; Shen Z; Yang W; Jiang W; Sun Y; Safe S; Guo S
    Diabetes; 2023 Sep; 72(9):1193-1206. PubMed ID: 37343276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-β1/Smad3 Pathway Targets PP2A-AMPK-FoxO1 Signaling to Regulate Hepatic Gluconeogenesis.
    Yadav H; Devalaraja S; Chung ST; Rane SG
    J Biol Chem; 2017 Feb; 292(8):3420-3432. PubMed ID: 28069811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic p38α MAPK controls gluconeogenesis via FOXO1 phosphorylation at S273 during glucagon signalling in mice.
    Yang W; Liao W; Li X; Ai W; Pan Q; Shen Z; Jiang W; Guo S
    Diabetologia; 2023 Jul; 66(7):1322-1339. PubMed ID: 37202506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dehydroabietic acid reverses TNF-α-induced the activation of FOXO1 and suppression of TGF-β1/Smad signaling in human adult dermal fibroblasts.
    Wang XW; Yu Y; Gu L
    Int J Clin Exp Pathol; 2014; 7(12):8616-26. PubMed ID: 25674226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigallocatechin Gallate Inhibits Hepatic Glucose Production in Primary Hepatocytes via Downregulating PKA Signaling Pathways and Transcriptional Factor FoxO1.
    Li X; Chen Y; Shen JZ; Pan Q; Yang W; Yan H; Liu H; Ai W; Liao W; Guo S
    J Agric Food Chem; 2019 Apr; 67(13):3651-3661. PubMed ID: 30875211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of FOXO1 ameliorates the podocyte epithelial-mesenchymal transition induced by high glucose in vitro and in vivo.
    Du M; Wang Q; Li W; Ma X; Wu L; Guo F; Zhao S; Huang F; Wang H; Qin G
    Biochem Biophys Res Commun; 2016 Mar; 471(4):416-22. PubMed ID: 26902117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of TGF-β1/Smad3 Signaling in Carbon Tetrachloride-Induced Acute Liver Injury in Mice.
    Niu L; Cui X; Qi Y; Xie D; Wu Q; Chen X; Ge J; Liu Z
    PLoS One; 2016; 11(5):e0156090. PubMed ID: 27224286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redirecting TGF-
    Qiao X; Rao P; Zhang Y; Liu L; Pang M; Wang H; Hu M; Tian X; Zhang J; Zhao Y; Wang XM; Wang C; Yu H; Guo F; Cao Q; Wang Y; Wang YM; Zhang GY; Lee VW; Alexander SI; Zheng G; Harris DCH
    J Am Soc Nephrol; 2018 Feb; 29(2):557-570. PubMed ID: 29180394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FOXO1 transcription factor regulates chondrogenic differentiation through transforming growth factor β1 signaling.
    Kurakazu I; Akasaki Y; Hayashida M; Tsushima H; Goto N; Sueishi T; Toya M; Kuwahara M; Okazaki K; Duffy T; Lotz MK; Nakashima Y
    J Biol Chem; 2019 Nov; 294(46):17555-17569. PubMed ID: 31601652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FoxO1 is a crucial mediator of TGF-β/TAK1 signaling and protects against osteoarthritis by maintaining articular cartilage homeostasis.
    Wang C; Shen J; Ying J; Xiao D; O'Keefe RJ
    Proc Natl Acad Sci U S A; 2020 Dec; 117(48):30488-30497. PubMed ID: 33199631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FoxO1 mediates TGF-beta1-dependent cardiac myofibroblast differentiation.
    Vivar R; Humeres C; Muñoz C; Boza P; Bolivar S; Tapia F; Lavandero S; Chiong M; Diaz-Araya G
    Biochim Biophys Acta; 2016 Jan; 1863(1):128-38. PubMed ID: 26518453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IRS-2 mediates the antiapoptotic effect of insulin in neonatal hepatocytes.
    Valverde AM; Fabregat I; Burks DJ; White MF; Benito M
    Hepatology; 2004 Dec; 40(6):1285-94. PubMed ID: 15565601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXO1 promotes wound healing through the up-regulation of TGF-β1 and prevention of oxidative stress.
    Ponugoti B; Xu F; Zhang C; Tian C; Pacios S; Graves DT
    J Cell Biol; 2013 Oct; 203(2):327-43. PubMed ID: 24145170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear forkhead box O1 controls and integrates key signaling pathways in hepatocytes.
    Naïmi M; Gautier N; Chaussade C; Valverde AM; Accili D; Van Obberghen E
    Endocrinology; 2007 May; 148(5):2424-34. PubMed ID: 17303659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of over-expressed forkhead transcription factor O1 on high glucose induced extracellular matrix secretion in rat mesangial cells].
    Guo F; Wang Q; Qin G; Zhou Y; Wu L; Liu F
    Zhonghua Yi Xue Za Zhi; 2014 Jun; 94(24):1899-904. PubMed ID: 25154998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Forkhead transcription factor FoxO1 inhibits insulin- and transforming growth factor-beta-stimulated plasminogen activator inhibitor-1 expression.
    Jung YA; Lee KM; Kim MK; Jung GS; Seo YJ; Kim HS; Cho HC; Lee KU; Park KG; Lee IK
    Biochem Biophys Res Commun; 2009 Sep; 386(4):757-61. PubMed ID: 19563779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of nuclear steroid receptors by ursodeoxycholic acid inhibits TGF-beta1-induced E2F-1/p53-mediated apoptosis of rat hepatocytes.
    Solá S; Castro RE; Kren BT; Steer CJ; Rodrigues CM
    Biochemistry; 2004 Jul; 43(26):8429-38. PubMed ID: 15222754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-linked inhibitor of apoptosis (XIAP) inhibits c-Jun N-terminal kinase 1 (JNK1) activation by transforming growth factor beta1 (TGF-beta1) through ubiquitin-mediated proteosomal degradation of the TGF-beta1-activated kinase 1 (TAK1).
    Kaur S; Wang F; Venkatraman M; Arsura M
    J Biol Chem; 2005 Nov; 280(46):38599-608. PubMed ID: 16157589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.